INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 34 filers reported holding INFLARX NV in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | -99.9% | 1,000 | -98.8% | 0.00% | -100.0% |
| Q1 2019 | $3,261,000 | +156.4% | 86,317 | +146.6% | 0.00% | +100.0% |
| Q4 2018 | $1,272,000 | -54.9% | 35,000 | -57.4% | 0.00% | 0.0% |
| Q3 2018 | $2,820,000 | +23.9% | 82,192 | +16.4% | 0.00% | 0.0% |
| Q2 2018 | $2,276,000 | +125.6% | 70,600 | +101.7% | 0.00% | – |
| Q1 2018 | $1,009,000 | +37.7% | 35,000 | 0.0% | 0.00% | – |
| Q4 2017 | $733,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 732,670 | $27,688,000 | 11.07% |
| Cormorant Asset Management, LP | 2,590,000 | $97,876,000 | 6.62% |
| RA Capital Management | 2,810,708 | $106,217,000 | 4.58% |
| Redmile Group, LLC | 2,182,638 | $82,482,000 | 2.41% |
| EMORY UNIVERSITY | 71,884 | $2,716,000 | 1.91% |
| Artal Group S.A. | 825,000 | $31,177,000 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 175,414 | $6,629,000 | 0.89% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,500 | $1,223,000 | 0.45% |
| Birchview Capital, LP | 16,000 | $605,000 | 0.38% |
| Eventide Asset Management | 275,000 | $10,392,000 | 0.36% |